WALTHAM, Mass.–( BUSINESS WIRE )–The Board of Directors of Revvity, Inc. (NYSE: RVTY), today paid a dividend of $0.07 per share. This dividend is payable on February 7, 2025 to all shareholders of record at the close of business on January 17, 2025.
About Revvity
At Revvity, inspiration is impossible, and a call to action is. Revvity provides life science solutions, technologies, technologies and services that deliver a complete workflow from discovery to development, and diagnosis to treatment. Revvity is revolutionizing what's possible in healthcare, with special focus areas in translational multi-omics technology, biomarker identification, imaging, prognostication, screening, detection and diagnosis, informatics and more.
With 2023 revenues of $2.7 billion and more than 11,000 employees, Revvity serves clients across pharmaceutical and biotech, diagnostic labs, academia and government. It is part of the S&P 500 index and has clients in more than 190 countries.
Stay updated by following our Newsroom, LinkedIn, XYouTube, Facebook (NASDAQ:) and Instagram.
View the source version on businesswire.com:
Media relations:
Murray said
(781) 462-5126
chet.murray@revvity.com
Investor Relations:
Steve Willoughby
steve.willoughby@revvity.com
Source: Revvity
